Fred Alger Management LLC Acquires New Position in Integer Holdings Co. (NYSE:ITGR)

Fred Alger Management LLC acquired a new stake in Integer Holdings Co. (NYSE:ITGR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 19,204 shares of the medical equipment provider's stock, valued at approximately $2,545,000. Fred Alger Management LLC owned about 0.06% of Integer as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of ITGR. Mather Group LLC. raised its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in Integer during the fourth quarter valued at $27,000. R Squared Ltd acquired a new stake in shares of Integer during the fourth quarter worth $44,000. Sterling Capital Management LLC lifted its position in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after buying an additional 279 shares during the last quarter. Finally, Principal Securities Inc. boosted its holdings in shares of Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after buying an additional 152 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Insider Transactions at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.16% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Raymond James raised their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Benchmark cut their price target on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Oppenheimer downgraded Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. KeyCorp cut their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Finally, StockNews.com lowered shares of Integer from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $145.56.

Integer Stock Performance

ITGR remained flat at $120.70 on Tuesday. 651,985 shares of the company were exchanged, compared to its average volume of 366,806. The stock has a market cap of $4.21 billion, a P/E ratio of 35.92, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a 50 day moving average of $118.39 and a two-hundred day moving average of $129.73. Integer Holdings Co. has a 12-month low of $104.93 and a 12-month high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.14 earnings per share. Research analysts predict that Integer Holdings Co. will post 6.01 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.